There is a dire need to prepare undergraduate and graduate students to assess and support a patient's spiritual needs. Addressing spiritual care content as a clinical and educational priority will promote a patient-centred approach for spiritual care and can further shape nursing curricula, policies, guidelines and assessment tools.
Objective
The objective of the study was to evaluate college students’ perceptions and behavioral intentions related to a new long‐acting reversible contraceptive (LARC) for people with penises: non‐hormonal intravas injectable gel (NH‐IVIG).
Design and Sample
Data collection utilized predictive constructs from the theory of planned behavior. An online questionnaire surveyed undergraduates (ages 18–24 years) at a Midwestern, liberal arts college (N = 460).
Results
Of potential NH‐IVIG users, 28.6% of males and 51.4% of females reported being overall likely to use or encourage its usage. The top three hypothetical NH‐IVIG promoters were low cost, reversibility, and infrequent administration. High cost, new product uncertainties, plus administration via injection for the males, were the most frequently cited NH‐IVIG deterrents. A majority of potential users indicated intentions to use protective barriers or other contraceptives simultaneously with NH‐IVIG; females were more likely overall. Most respondents (males, 90.4%; females, 98.5%) agreed all sexual partners should be equally responsible for contraception. Over half trusted both males and females to use contraception, but females were significantly more trusted and trusting.
Conclusion
Understanding factors influencing NH‐IVIG usage can direct initiatives for sperm‐targeted LARCs to mitigate risk behaviors and optimize public health promotion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.